Browse 24914 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
November 9th, 2022 |
NIDDK Research Education Program Utilizing Stimulating Peripheral Activity to Relieve Conditions (SPARC) - Generated Resources (R25 Clinical Trial Not Allowed) |
National Institutes of Health |
January 31st, 2023 |
NIDDK Education Program Grants (R25 Clinical Trial Not Allowed) |
National Institutes of Health |
November 6th, 2020 |
Urban Indian Education and Research Program, Competing Supplement |
Indian Health Service |
January 6th, 2021 |
Elucidation of mechanisms underlying complex morbidities of SUD and other mental Illnesses in people living with HIV/AIDS (R01 Clinical Trial Optional) |
National Institutes of Health |
January 15th, 2021 |
Collaborative Approaches to Engineer Biology for Cancer Applications (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
December 15th, 2020 |
Community Opioid Intervention Pilot Projects |
Indian Health Service |
January 7th, 2024 |
NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed) |
National Institutes of Health |
January 8th, 2021 |
FY 2021 Farm to School Grants |
Food and Nutrition Service |
January 7th, 2024 |
Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
January 7th, 2024 |
Discovery of Cell-based Chemical Probes for Novel Brain Targets (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
January 29th, 2021 |
New Cohorts for Environmental Exposures and Cancer Risk (CEECR; UG3/UH3 Clinical Trial Not Allowed) |
National Institutes of Health |
May 26th, 2021 |
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Research Resource (U24) (Clinical Trial Optional) |
National Institutes of Health |
May 26th, 2021 |
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Administrative Resource Core (U24) (Clinical Trial Optional) |
National Institutes of Health |
February 1st, 2021 |
Utilizing In Vitro Functional Genomics Advances for Gene-Environment (G x E) Discovery and Validation (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
October 10th, 2023 |
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed) |
National Institutes of Health |
October 10th, 2023 |
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed) |
National Institutes of Health |
March 17th, 2021 |
From Genomic Association to Causation: A Convergent Neuroscience Approach to Linking Levels of Analysis for Understanding Neuropsychiatric Disorders (U19 Clinical Trial Optional) |
National Institutes of Health |
April 15th, 2021 |
Developing and Disseminating Targeted Immunization Materials |
Centers for Disease Control NCIRD |
August 9th, 2021 |
Enhancing Global Health Security: Strengthening Public Health Surveillance Systems and Preparedness Globally |
Centers for Disease Control CGH |
February 24th, 2023 |
NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed) |
National Institutes of Health |
|
January 29th, 2021 |
New Cohorts for Environmental Exposures and Cancer Risk (CEECR) Coordinating Center (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
December 14th, 2020 |
Rural Policy Analysis Program |
Health Resources and Services Administration |
May 26th, 2021 |
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia (U01 Clinical Trial Optional) |
National Institutes of Health |
July 23rd, 2023 |
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) |
National Institutes of Health |
September 7th, 2023 |
National Dental Practice-Based Research Network Clinical Trial or Observational Study Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Optional) |
National Institutes of Health |
September 13th, 2023 |
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) |
National Institutes of Health |
September 13th, 2023 |
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) |
National Institutes of Health |
February 18th, 2021 |
Coccidioidomycosis Collaborative Research Centers (U19 Clinical Trial Not Allowed) |
National Institutes of Health |
September 5th, 2022 |
Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed) |
National Institutes of Health |
April 12th, 2021 |
Research Grants to Develop or Identify Effective Strategies to Prevent Overdose Involving Illicit Stimulants and Polysubstance Use Involving Stimulants |
Centers for Disease Control and Prevention ERA |
July 16th, 2021 |
Shoulder to Shoulder: Accompanying Ministries of Health in Central America in Strengthening Local and Global Health Security |
Centers for Disease Control CGH |
February 8th, 2021 |
A Multidisciplinary Approach to Study Vaccine-elicited Immunity and Efficacy against Malaria (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
March 22nd, 2021 |
Research Grants for Preventing Violence and Violence Related Injury (R01) |
Centers for Disease Control and Prevention ERA |
April 5th, 2021 |
Rigorous Evaluation of Policies for their Impacts on the Primary Prevention of Multiple Forms of Violence |
Centers for Disease Control and Prevention ERA |
February 3rd, 2021 |
MD-PhD Training Program in Alzheimer's Disease and Related Dementias and the Behavioral and Social Sciences (T32 Clinical Trial Not Allowed) |
National Institutes of Health |
December 8th, 2020 |
Cooperative Research Agreements Related to the World Trade Center Health Program (U01) |
Centers for Disease Control and Prevention ERA |
December 10th, 2020 |
Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
July 23rd, 2023 |
Successor-in-Interest (Type 6 Parent Clinical Trial Optional) |
National Institutes of Health |
April 2nd, 2021 |
Building Sustainable Health Systems and Laboratory Services in Cote d'Ivoire under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
January 7th, 2023 |
Multidisciplinary Approaches to HIV-Associated Comorbidities and Prioritizing Intervention Targets (R01 Clinical Trial Not Allowed) |
National Institutes of Health |